Cargando…
Two Pediatric Osteosarcoma Cases with Delayed Methotrexate Excretion: Its Clinical Course and Management
High-dose methotrexate (MTX) chemotherapy extends the duration of hospitalization and introduces the risks of serious complications related to delayed MTX excretion. The treatment of delayed MTX excretion is largely dependent on invasive measures such as hemodialysis because the clinical data regard...
Autores principales: | Lee, Kang Min, Lee, Hee Woo, Kim, Seung Yeon, Lee, Hyeon Jeong, Kim, Dong Hwan, Cho, Joongbum, Kim, Dong Ho, Lim, Jung Sub, Lee, Jin Kyung, Lee, Jun Ah |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072537/ https://www.ncbi.nlm.nih.gov/pubmed/21509165 http://dx.doi.org/10.4143/crt.2011.43.1.67 |
Ejemplares similares
-
Delayed High-dose Methotrexate Excretion and Influencing Factors in Osteosarcoma Patients
por: Zhang, Wei, et al.
Publicado: (2016) -
Assessment of Chemotherapy Response Using FDG-PET in Pediatric Bone Tumors: A Single Institution Experience
por: Kim, Dong Hwan, et al.
Publicado: (2011) -
Lymphocyte-monocyte ratio at day 14 of first cisplatin-doxorubicin chemotherapy is associated with treatment outcome of pediatric patients with localized osteosarcoma
por: Lee, Jun Ah, et al.
Publicado: (2019) -
Bone mineral density change during adjuvant chemotherapy in pediatric osteosarcoma
por: Ahn, Ju Hyun, et al.
Publicado: (2015) -
Efficacy of pamidronate in pediatric osteosarcoma patients with low bone mineral density
por: Lim, Se Won, et al.
Publicado: (2016)